scholarly journals The copper content in the blood plasma of children with different types of short stature

2020 ◽  
Vol 73 (2) ◽  
pp. 266-271
Author(s):  
Tamila V. Sorokman ◽  
Snezhana V. Sokolnyk ◽  
Oleksandra-Maria V. Popelyuk ◽  
Tetyana O. Bezruk ◽  
Olena V. Makarova

The aim: to investigate the copper content in blood serum of children with different short stature types. Materials and methods: In the first stage, a comprehensive survey of 258 school children aged 7-11 was carried out in Chernivtsi to assess the prevalence of short stature children of school-age. In the second stage, a comparative study of 42 children aged 3 to 15 years with different types of short stature was conducted. Research: anthropometry, determination of growth hormone, TSH, IGF-1, and copper level in blood plasma. Results: The largest growth rate in children with somatotropic insufficiency, the syndrome of a biologically inactive growth hormone ranged from 4.1 cm/year to 1.6 cm/year, the ones with a family constitutional low-growth – from 5.7 cm/year to 3.3 cm/year. In 57 cases, that makes 1% of children with short stature, the blood plasma level of copper made less and rated 0.89 ± 0.04 μg / ml, which is believed to be lower (pу0,001) the average copper in children of the control group – 1.07 ± 0.02 μg / ml. Indices of copper in blood plasma in children with somatotropic insufficiency were the lowest and averaged 0.75 ± 0.03 μg / l, p<0.05. Conclusions: The lack of copper in the blood plasma is observed in most children with short stature, which indicates the need for appropriate correction.

2015 ◽  
Vol 6 (2) ◽  
pp. 108-112 ◽  
Author(s):  
O. V. Netronina

The level of free and bound forms of sialic acids (SА) was investigated in chronic lymphocytic leukemia (CLL) and at different stages of receiving chemotherapy. Determination of sialic acid in blood plasma of patients with CLL before treatment were carried out on the first day and 2 months after taking chemotherapy drugs for combination schemes. Hematologically healthy donors represented the control group. Determination of SA was conducted by thiobarbituric method using trichloroacetic acid for distribution of total sialic acids onto free, protein bound sialic acid, and oligo bound sialic acid. Levelof free sialic acid in serum in chronic lymphocytic leukemia was equal to 43.2% compared to the total number of plasma. On the first day of chemotherapy on background of the general level of oligo bound sialic acids we observed increase in free sialic acid by 24.2% compared to patients not receiving treatment. The level of sialic acids increased 2.6 times compared to norm and featured no significant changes at different stages of treatment. The concentration of sialic acids bound to proteins at 73.4% was lower compared to the control group. After receiving chemotherapy on the first day there was a decline of this indicator to 56.2% compared to groups of patients before treatment. Two months after the treatment the level of all parameters under study returned back to the values obtained at the start of treatment. This data can serve as an additional efficiency criterion of the chemotherapy.


Talanta ◽  
2021 ◽  
Vol 225 ◽  
pp. 121900
Author(s):  
Lukasz Oldak ◽  
Anna Sankiewicz ◽  
Beata Żelazowska-Rutkowska ◽  
Bogdan Cylwik ◽  
Zenon Lukaszewski ◽  
...  

1953 ◽  
Vol 204 (1) ◽  
pp. 147-152 ◽  
Author(s):  
Shirley F. McCann ◽  
M. Laskowski

2020 ◽  
Author(s):  
Artem V. Baklykov ◽  
Konstantin A. Chistiakov ◽  
Dmitry S. Kopchuk ◽  
Grigory V. Zyryanov ◽  
Gennady L. Rusinov ◽  
...  
Keyword(s):  

Author(s):  
Les Ebdon ◽  
Andrew Fisher ◽  
Norman B. Roberts ◽  
Magdi Yaqoob
Keyword(s):  
Icp Ms ◽  

Sign in / Sign up

Export Citation Format

Share Document